Garg Harshit, Kumar Rajeev
Department of Urology, All India Institute of Medical Sciences, New Delhi, India.
Asian J Androl. 2016 Mar-Apr;18(2):222-8. doi: 10.4103/1008-682X.171657.
Varicocele-associated male infertility has classically been managed using surgery or assisted reproductive techniques. With increasing evidence of oxidative stress as a pathophysiological factor in varicocele-associated infertility, medical therapy especially antioxidants might become a treatment option with lower risks. We reviewed the existing literature on the role of various medical agents in the management of male infertility attributed to varicoceles. Medical therapy is typically evaluated in three different situations such as (a) comparison of two drugs or one drug with placebo, (b) comparison of drugs versus surgery, and (c) comparison of drugs as adjuvant therapy with surgery versus drug therapy alone. Due to heterogeneity of data and lack of well-conducted studies, there is insufficient data to recommend routine use of medical therapy for men with varicocele-associated infertility and surgery remains the treatment of choice. Pregnancy and live birth rates are usually not reported in most studies and mere improvement in sperm parameters or antioxidant capacity is insufficient to support its routine use. Antioxidant therapy is a potential option due to its theoretical benefit, data from preclinical studies, and lack of major side effects. Adjuvant therapy with antioxidants after surgical repair of varicocele may improve the outcome and is a potential area for further research.
精索静脉曲张相关性男性不育症传统上采用手术或辅助生殖技术进行治疗。随着氧化应激作为精索静脉曲张相关性不育症病理生理因素的证据越来越多,药物治疗尤其是抗氧化剂可能成为风险较低的治疗选择。我们回顾了现有关于各种药物在治疗精索静脉曲张所致男性不育症中作用的文献。药物治疗通常在三种不同情况下进行评估,例如(a)两种药物或一种药物与安慰剂的比较,(b)药物与手术的比较,以及(c)药物作为辅助治疗与手术联合使用与单独药物治疗的比较。由于数据的异质性和缺乏精心设计的研究,没有足够的数据推荐对精索静脉曲张相关性不育症男性常规使用药物治疗,手术仍然是首选治疗方法。大多数研究通常未报告妊娠和活产率,仅仅精子参数或抗氧化能力的改善不足以支持其常规使用。抗氧化剂治疗因其理论益处、临床前研究数据以及缺乏重大副作用而成为一种潜在选择。精索静脉曲张手术修复后使用抗氧化剂进行辅助治疗可能会改善治疗效果,是一个值得进一步研究的潜在领域。